DNA Stock 12 Month Analyst Forecast
Eps Overview
Consensus Rating
Consensus Price Target
Highest Price Target
$14.00
61.48% Upside
Mean Price Target
$10.67
23.03% Upside
Lowest Price Target
$9.00
3.81% Upside
Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Last Updated On Mar 12, 2026
Actual EPS vs Estimated EPS
DNA Earnings Per Share (EPS) History
According to financial reports, DNA (NYSE: DNA) reported an actual EPS of $-1.39 for the quarter ending on May 07, 2026, compared to an estimated $-1.21115, resulting in a 14.77% surprise. In the prior quarter (Feb 26, 2026), DNA recorded an actual EPS of $-1.42 with a -21.11% surprise. See DNA's full earnings history.
Earnings History
EPS Surprise Factor Analysis
DNA has experienced notable EPS surprises, with the latest quarter ending May 07, 2026 showing a 14.77% beat. Previously, the quarter ending Feb 26, 2026 recorded a -21.11% miss. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
| Report Date | Actual | Forecast | Surprise Factor |
|---|---|---|---|
| May 07, 2026 | -1.39 | -1.21115 | +14.77% |
| Feb 26, 2026 | -1.42 | -1.8 | -21.11% |
| Nov 06, 2025 | -1.45 | -1.24 | +16.94% |
| Aug 07, 2025 | -1.1 | -1.44 | -23.61% |
| May 06, 2025 | -1.58 | -1.23 | +28.46% |
| Feb 25, 2025 | -1.82 | -1.45 | +25.52% |

